Analgesics in Switzerland - New Market Study Published

From: Fast Market Research, Inc.
Published: Fri Nov 21 2014


Sales of analgesics are strongly influenced by the flu season. The number of people affected by flu at the beginning of 2013 was high compared to the previous years. The intense flu season benefited sales of analgesics, which are used to treat various flu symptoms, such as headache and high fever. However, analgesics is a mature and saturated category in Switzerland and there continued to be a shift from systemic analgesics towards topical analgesics/anaesthetic. In order to save money, many Swiss consumers visit the doctor to receive a prescription rather than purchasing OTC analgesics in chemists/pharmacies. This trend continued in 2013.

Full Report Details at
- http://www.fastmr.com/prod/887749_analgesics_in_switzerland.aspx?afid=303

Competitive Landscape

Vifor Pharm AG and Bayer (Schweiz) AG continued to lead analgesics in 2013. Vifor Pharma is by far the leading player in the ibuprofen category, where it recorded a 64% value share in 2013. Ibuprofen sales have strongly increased over the review period and Vifor Pharma's leading brand, Algifor, is a popular and trusted ibuprofen product in Switzerland. Algifor increased its value share by one percentage point in 2013 to extend its leadership. Perskindol is another popular brand by Vifor Pharma. Within the topical analgesics/anaesthetic category, it ranked second and posted an 18% value share. Bayer (Schweiz) AG is the leader within the aspirin category; its brands Aspirin C and Aspirin are particularly strong in the aspirin category, where they ranked first and second respectively in 2013. The vitamin supplement in Aspirin C proved to be successful in 2013, showing an increase in value share.

Industry Prospects

Analgesics is expected to register a positive value CAGR at constant 2013 prices over the forecast period. Switzerland has an ageing population, which will help to support sales of analgesics going forward. A higher average age means an increased chance that people may suffer from pain, which in turn will drive sales of pain-relieving products.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Switzerland market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Analgesics in Japan
- Analgesics in Portugal
- Analgesics in Romania
- Analgesics in Saudi Arabia
- Analgesics in the Czech Republic

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »